Alpine Bank Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$440K Buy
1,251
+355
+40% +$127K 0.06% 115
2025
Q4
$293K Sell
896
-45
-5% -$14.3K 0.04% 128
2025
Q3
$266K Buy
941
+8
+0.9% +$2.32K 0.04% 135
2025
Q2
$261K Sell
933
-100
-10% -$28.3K 0.04% 127
2025
Q1
$322K Buy
+1,033
New +$305K 0.05% 112
2024
Q3
$359K Buy
+1,115
New +$365K 0.06% 114

Other funds holding AMGN

Alpine Bank Wealth Management's AMGN Position: Q1 2026 in Review

Alpine Bank Wealth Management increased its Amgen (AMGN) stake by 40% in Q1 2026, buying an estimated $127K and bringing the position to 1,251 shares worth $440K. The position accounts for 0.06% of the portfolio, ranked #115.

Alpine Bank Wealth Management first reported a position in AMGN in Q3 2024 and has held it in 6 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alpine Bank Wealth Management held 1,251 shares of Amgen worth $440K as of Q1 2026.
  • Alpine Bank Wealth Management bought 355 Amgen shares in Q1 2026, an estimated $127K.
  • Amgen made up 0.06% of Alpine Bank Wealth Management's portfolio in Q1 2026, its #115 holding.
  • Alpine Bank Wealth Management first reported a position in Amgen in Q3 2024 and has held it in 6 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.